Inactive Instrument

Pilot Therapeutics Holdings Inc. Stock price Other OTC

Equities

PLTT

US7216501095

Pharmaceuticals

Sales 2001 - Sales 2002 - Capitalization 27.06M
Net income 2001 -7M Net income 2002 -6M EV / Sales 2001 -
Net Debt 2001 2.01M Net Debt 2002 2.59M EV / Sales 2002 -
P/E ratio 2001
-5.69 x
P/E ratio 2002
-4.01 x
Employees -
Yield 2001 *
-
Yield 2002
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Pilot Therapeutics Holdings, Inc. is a holding company for Pilot Therapeutics, Inc. and is a specialty pharmaceutical company. Through lipid profiling and metabolism, the Company has developed a proprietary, lipid and genomic profiling research platform, termed Functional Liponomics. Using Functional Liponomics, the Company is developing novel, branded, therapeutic, pharmaceutical and over-the-counter (OTC) medical food products that are specifically designed to address dysfunctional lipid metabolism in chronic human diseases such as asthma, coronary heart disease, allergic rhinitis, cancer, cystic acne and rheumatoid arthritis. Pilot expects to launch its first product, Airozin, for adults and children regionally in April 2003 and nationally by 2004.
More about the company
  1. Stock
  2. Equities
  3. Stock Pilot Therapeutics Holdings Inc.
  4. Stock Pilot Therapeutics Holdings Inc. - Other OTC